+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Synthetic Injectable Bone Graft Market by Application, Product Type, End User, Form - Global Forecast to 2030- Product Image
Synthetic Injectable Bone Graft Market by Application, Product Type, End User, Form - Global Forecast to 2030- Product Image
Sale

Synthetic Injectable Bone Graft Market by Application, Product Type, End User, Form - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6085249
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Setting the Stage for Synthetic Injectable Bone Graft Innovation

The synthetic injectable bone graft market has emerged as a pivotal driver of innovation in regenerative medicine and minimally invasive surgery. As patient demand for faster healing and reduced surgical trauma continues to rise, industry stakeholders are compelled to refine biomaterial formulations that mimic native bone properties while ensuring ease of delivery. This executive summary introduces the critical advancements, market forces, and strategic imperatives shaping the landscape of injectable graft technologies.

Through a comprehensive lens, we examine how synthetic grafts are supplanting traditional autografts and allografts by offering scalable manufacturing, consistent quality profiles, and lower infection risk. This introduction sets the stage for a deep dive into transformative shifts in research and development, supply chain dynamics, and regional trends that collectively influence adoption curves and competitive positioning.

Charting the Technological and Regulatory Revolution in Bone Grafting

In recent years, the synthetic injectable bone graft sector has experienced profound transformation driven by material science breakthroughs and clinical workflow optimization. New composite formulations marrying calcium phosphates with advanced polymers have enhanced osteoconductivity and injectability, enabling surgeons to tailor graft viscosity and resorption kinetics to specific defect geometries. At the same time, digital surgical planning tools and intraoperative imaging have elevated procedural precision, fostering broader acceptance among orthopedic, dental, and spinal fusion specialists.

Regulatory agencies across key markets have responded by streamlining approval pathways for well-characterized synthetic materials, encouraging manufacturers to invest in robust safety and performance evidence. This regulatory alignment has catalyzed partnerships between biomaterials companies and contract research organizations, yielding accelerated timelines from bench to operating room. As a result, market entrants can navigate clinical validation with greater clarity, fueling a virtuous cycle of innovation and patient access.

Assessing the 2025 United States Tariff Implications on Supply Chains

In 2025, newly enacted tariffs in the United States targeting calcium phosphate raw materials and advanced polymeric carriers are reshaping the cost structures of synthetic injectable graft suppliers. These levies have elevated import expenses, prompting manufacturers to reevaluate global sourcing strategies and secure domestic alternative feedstocks. The resulting cost increases for implantable products have driven negotiations on price adjustments with hospital purchasing teams and ambulatory surgical centers.

To mitigate tariff-induced pressures, several leading suppliers have announced strategic investments in U.S.-based manufacturing capacity, aiming to localize production and preserve margin stability. At the same time, collaborative frameworks between industry associations and federal agencies are exploring tariff relief measures for critical biomaterials. These collective efforts underscore the sector’s commitment to safeguarding patient access and sustaining innovation despite evolving trade barriers.

Unveiling Core Market Segments Through Multidimensional Analysis

Our segmentation analysis by application reveals four primary clinical domains: dental surgery subdividing into implantology and periodontal regeneration that demand precise graft placement and rapid tissue integration; orthopedic surgery encompassing fracture fixation and joint replacement where mechanical stability and long-term biocompatibility are paramount; spinal fusion procedures differentiated between cervical and lumbar fusion with an emphasis on controlled osteogenesis in confined anatomical spaces; and trauma repair covering bone defect repair and nonunion treatment requiring tailored resorption rates and injectable form stability.

When examining the market through the lens of product type, beta tricalcium phosphate emerges in both injectable granules and injectable putty formats offering variable porosity profiles. Composite grafts integrate HA collagen composite or TCP-HA composite matrices to balance strength with cellular adhesion. Demineralized bone matrix is available as injectable gel or putty, providing bioactive signaling molecules for regenerative stimulation. Hydroxyapatite appears in injectable granules and paste variations, lending structural scaffolding while accommodating diverse procedural requirements.

Evaluating end user distribution, ambulatory surgical centers comprise hospital-affiliated and standalone facilities requiring streamlined supply and on-demand inventory. Dental clinics range from general dentistry to specialized oral surgery practices where workflow efficiency and product customization are critical. Hospitals, both private and public, leverage scale procurement for inpatient and outpatient bone graft procedures. Specialized centers including orthopedic specialty clinics and dedicated spinal centers demand high-performance formulations with documented clinical outcomes.

In terms of form, injectable granules are offered as sterile and non-sterile options to align with procurement protocols, while injectable paste is classified by high viscosity or standard viscosity to match delivery devices. Injectable putty is formulated as single component systems or two component kits, enabling on-site mixing and tunable handling properties.

Dissecting Regional Dynamics Shaping Market Momentum

The Americas region benefits from robust healthcare infrastructure and advanced reimbursement schemes, driving early adoption of next-generation injectable graft solutions in both surgical and dental applications. North American hospitals and specialized centers are investing in point-of-care manufacturing capabilities to enhance supply chain resilience in the face of global trade uncertainties.

Europe, Middle East & Africa is characterized by diverse regulatory landscapes and variable health economics, yet it presents significant growth opportunities as governments expand budget allocations for orthobiologics. Western European markets are integrating synthetic grafts into national clinical guidelines, while emerging economies in the Middle East and Africa are prioritizing large-scale procurement to support trauma and reconstructive surgery initiatives.

Asia-Pacific stands out for its rapid hospital expansion and increasing procedural volumes across spine, dental, and trauma care segments. Strategic partnerships between regional distributors and global biomaterials developers have facilitated technology transfer and local manufacturing alliances, accelerating market penetration in key countries such as China, India, Japan, and Australia.

Deciphering Competitive Tactics and Partnership Strategies

Major industry players are intensifying their focus on synthetic injectable bone graft portfolios through targeted acquisitions and collaborative R&D alliances. Leading biomaterials developers have integrated proprietary polymer carriers with calcium phosphate cores to differentiate their injectable offerings and secure regulatory clearances across multiple jurisdictions. Mid-sized enterprises are forging co-development agreements with contract manufacturing organizations to expedite scale-up and reduce time to market.

Several companies are advancing clinical pipelines with next-generation formulations incorporating bioactive peptides and growth factors, seeking to establish differentiated clinical claims. Others have strengthened distribution networks by partnering with specialized medical device firms, enabling seamless integration of injectable grafts into existing surgical instrument platforms. These strategic moves highlight the competitive imperative to deliver clinically validated, easy-to-use products that align with evolving surgeon preferences and hospital purchasing criteria.

Actionable Strategies to Elevate Market Leadership

Industry leaders should prioritize investment in advanced material science research to develop injectable grafts with tunable resorption rates, enhanced bioactivity, and improved handling properties. By leveraging additive manufacturing techniques and high-throughput screening, organizations can accelerate innovation cycles and deliver formulations that meet the nuanced demands of diverse surgical specialties.

Diversifying the supply chain for calcium phosphate precursors and polymeric carriers will mitigate exposure to trade disruptions and tariff volatility. Establishing strategic alliances with raw material providers or exploring in-house synthesis capabilities can strengthen procurement resilience and preserve cost competitiveness.

Engaging proactively with regulatory bodies to align on evidentiary requirements and streamline approval pathways will expedite market access. Companies can achieve this by participating in advisory committees, sharing real-world data from clinical registries, and collaborating on harmonized performance standards.

Enhancing customer engagement through digital platforms and surgeon training programs will drive adoption and reinforce brand positioning. Tailored educational initiatives that demonstrate clinical efficacy and procedural efficiency can influence key opinion leaders and accelerate conversion across hospital systems.

Pursuing symbiotic partnerships with implantable device manufacturers and surgical instrument companies will broaden distribution channels and create bundled solutions. Co-marketing agreements and integrated device-graft offerings can provide differentiated value propositions that meet the growing demand for turnkey surgical solutions.

Detailing the Rigorous Research Framework and Data Sources

This research draws on a robust methodology combining primary interviews with orthopedic surgeons, dental specialists, spinal fusion experts, and procurement officers across hospital and ambulatory settings. Complementing these insights, secondary data sources including peer-reviewed publications, regulatory filings, company reports, and industry association whitepapers were analyzed to validate clinical and commercial trends.

A multi-tiered framework was employed to evaluate technology readiness levels, regulatory landscapes, and reimbursement mechanisms. Geographic coverage encompassed the Americas, Europe, Middle East & Africa, and Asia-Pacific, ensuring balanced representation of mature and emerging markets. Quantitative and qualitative analyses were triangulated to safeguard data integrity and deliver a holistic understanding of the synthetic injectable bone graft ecosystem.

Synthesizing Key Insights and Pathways Forward

The synthetic injectable bone graft market stands at the confluence of material innovation, surgical precision, and strategic collaboration. As tariffs and regulatory reforms reshape supply chains, stakeholders must adopt agile operational models and differentiated product strategies. Segmentation insights reveal distinct requirements across applications, product types, end users, and formulations that demand tailored approaches for market entry and expansion.

Regional nuances underscore the importance of localized partnerships and regulatory engagement, while competitive dynamics emphasize the value of integrated solutions and clinical evidence. By aligning R&D investments with clear clinical needs and fostering supply chain resilience, industry participants can capitalize on the growing demand for minimally invasive, high-performance bone graft alternatives.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Dental Surgery
      • Implantology
      • Periodontal Regeneration
    • Orthopedic Surgery
      • Fracture Fixation
      • Joint Replacement
    • Spinal Fusion
      • Cervical Fusion
      • Lumbar Fusion
    • Trauma Repair
      • Bone Defect Repair
      • Nonunion Treatment
  • Product Type
    • Beta Tricalcium Phosphate
      • Injectable Granules
      • Injectable Putty
    • Composite Graft
      • Ha Collagen Composite
      • Tcp Ha Composite
    • Demineralized Bone Matrix
      • Gel
      • Putty
    • Hydroxyapatite
      • Injectable Granules
      • Injectable Paste
  • End User
    • Ambulatory Surgical Centers
      • Hospital Affiliated Centers
      • Standalone Centers
    • Dental Clinics
      • General Dentistry
      • Oral Surgery Practices
    • Hospitals
      • Private Hospitals
      • Public Hospitals
    • Specialized Centers
      • Orthopedic Specialty Centers
      • Spinal Centers
  • Form
    • Injectable Granules
      • Non Sterile Granules
      • Sterile Granules
    • Injectable Paste
      • High Viscosity
      • Standard Viscosity
    • Injectable Putty
      • Single Component
      • Two Component
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Medtronic plc
  • Bioventus, Inc.
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Alphatec Spine, Inc.
  • Biocomposites Ltd
  • Bonesupport AB

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Synthetic Injectable Bone Graft Market, by Application
8.1. Introduction
8.2. Dental Surgery
8.2.1. Implantology
8.2.2. Periodontal Regeneration
8.3. Orthopedic Surgery
8.3.1. Fracture Fixation
8.3.2. Joint Replacement
8.4. Spinal Fusion
8.4.1. Cervical Fusion
8.4.2. Lumbar Fusion
8.5. Trauma Repair
8.5.1. Bone Defect Repair
8.5.2. Nonunion Treatment
9. Synthetic Injectable Bone Graft Market, by Product Type
9.1. Introduction
9.2. Beta Tricalcium Phosphate
9.2.1. Injectable Granules
9.2.2. Injectable Putty
9.3. Composite Graft
9.3.1. Ha Collagen Composite
9.3.2. Tcp Ha Composite
9.4. Demineralized Bone Matrix
9.4.1. Gel
9.4.2. Putty
9.5. Hydroxyapatite
9.5.1. Injectable Granules
9.5.2. Injectable Paste
10. Synthetic Injectable Bone Graft Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Hospital Affiliated Centers
10.2.2. Standalone Centers
10.3. Dental Clinics
10.3.1. General Dentistry
10.3.2. Oral Surgery Practices
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
10.5. Specialized Centers
10.5.1. Orthopedic Specialty Centers
10.5.2. Spinal Centers
11. Synthetic Injectable Bone Graft Market, by Form
11.1. Introduction
11.2. Injectable Granules
11.2.1. Non Sterile Granules
11.2.2. Sterile Granules
11.3. Injectable Paste
11.3.1. High Viscosity
11.3.2. Standard Viscosity
11.4. Injectable Putty
11.4.1. Single Component
11.4.2. Two Component
12. Americas Synthetic Injectable Bone Graft Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Synthetic Injectable Bone Graft Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Synthetic Injectable Bone Graft Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. Stryker Corporation
15.3.3. Zimmer Biomet Holdings, Inc.
15.3.4. Medtronic plc
15.3.5. Bioventus, Inc.
15.3.6. NuVasive, Inc.
15.3.7. Orthofix Medical Inc.
15.3.8. Alphatec Spine, Inc.
15.3.9. Biocomposites Ltd
15.3.10. Bonesupport AB
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SYNTHETIC INJECTABLE BONE GRAFT MARKET MULTI-CURRENCY
FIGURE 2. SYNTHETIC INJECTABLE BONE GRAFT MARKET MULTI-LANGUAGE
FIGURE 3. SYNTHETIC INJECTABLE BONE GRAFT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SYNTHETIC INJECTABLE BONE GRAFT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SYNTHETIC INJECTABLE BONE GRAFT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SYNTHETIC INJECTABLE BONE GRAFT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PERIODONTAL REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY CERVICAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY LUMBAR FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BONE DEFECT REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NONUNION TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HA COLLAGEN COMPOSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TCP HA COMPOSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY GENERAL DENTISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORAL SURGERY PRACTICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY NON STERILE GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY STERILE GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HIGH VISCOSITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY STANDARD VISCOSITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SINGLE COMPONENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TWO COMPONENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 110. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 112. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 113. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 114. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 115. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 117. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 118. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 119. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 120. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 122. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 123. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 124. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 125. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 126. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 127. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 128. CANADA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 129. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 131. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 132. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 133. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 134. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 136. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 137. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 138. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 139. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 141. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 145. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 146. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 147. MEXICO SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 222. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 224. UNITED KINGDOM SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 225. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 227. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 228. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 229. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 230. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 232. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 233. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 234. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 235. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 237. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 238. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 239. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 240. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 241. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 242. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 243. GERMANY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 244. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 246. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 247. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 248. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 249. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 251. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 252. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 253. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 254. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 256. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 257. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 258. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 259. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 260. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 261. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 262. FRANCE SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPECIALIZED CENTERS, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE GRANULES, 2018-2030 (USD MILLION)
TABLE 280. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PASTE, 2018-2030 (USD MILLION)
TABLE 281. RUSSIA SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY INJECTABLE PUTTY, 2018-2030 (USD MILLION)
TABLE 282. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 284. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 285. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 286. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY TRAUMA REPAIR, 2018-2030 (USD MILLION)
TABLE 287. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY BETA TRICALCIUM PHOSPHATE, 2018-2030 (USD MILLION)
TABLE 289. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY COMPOSITE GRAFT, 2018-2030 (USD MILLION)
TABLE 290. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DEMINERALIZED BONE MATRIX, 2018-2030 (USD MILLION)
TABLE 291. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY HYDROXYAPATITE, 2018-2030 (USD MILLION)
TABLE 292. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 294. ITALY SYNTHETIC INJECTABLE BONE GRAFT MARKET SIZE, BY DENTAL CLINICS, 2018-2030 (USD MILLION)
TABLE 295. ITALY SYNTHETIC INJECTABLE BONE GRA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Synthetic Injectable Bone Graft market report include:
  • Johnson & Johnson
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Medtronic plc
  • Bioventus, Inc.
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Alphatec Spine, Inc.
  • Biocomposites Ltd
  • Bonesupport AB

Related Topics

Related Reports

Synthetic Dental Bone Graft Substitutes Market by Material Type, Application, Form Factor, End User, Technique - Global Forecast to 2030 - Product Image

Synthetic Dental Bone Graft Substitutes Market by Material Type, Application, Form Factor, End User, Technique - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Bone Grafts & Substitutes Market by Graft Type, Material, Form, Application, End User - Global Forecast to 2030 - Product Image

Bone Grafts & Substitutes Market by Graft Type, Material, Form, Application, End User - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Veterinary Bone Grafts And Substitutes Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Form, By Application, By Material, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Veterinary Bone Grafts And Substitutes Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Form, By Application, By Material, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Orthopedic Biomaterials Market Size, Share and Trend Analysis | Global | 2025-2031 | MedSuite | Includes: Bone Graft Substitutes Market, Orthopedic Growth Factors Market, and 3 more - Product Image

Orthopedic Biomaterials Market Size, Share and Trend Analysis | Global | 2025-2031 | MedSuite | Includes: Bone Graft Substitutes Market, Orthopedic Growth Factors Market, and 3 more

  • Report
  • 492 Pages
  • Global
From
Veterinary Bone Grafts and Substitutes Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Veterinary Bone Grafts and Substitutes Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.